iSpecimen Inc. (ISPC) Tops Q3 EPS by 12c

iSpecimen Inc. (NASDAQ: ISPC) reported Q3 EPS of ($0.23), $0.12 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.78 million versus the consensus estimate of $2.24 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'